J&J to Present at JP Morgan Health Care Conference In San Francisco January 7th, 2019
Dow 30 component Johnson & Johnson (JNJ) is a worldwide healthcare focused company that embraces research and science so that it can provide customers with innovative ideas, products, and services. Johnson & Johnson will be a participant in the 37th Annual JP Morgan Health Care Conference. The conference will take place on Monday, January 7th, 2019 at the Westin St. Francis in San Francisco, CA. The company will be represented by three individuals during a session scheduled for 2:30 p.m. Pacific Time: Joseph J. Wolk, Executive Vice President and Chief Financial Officer; Jennifer Taubert, Executive Vice President, Pharmaceuticals; and Ashley McEvoy, Executive Vice President, Medical Devices. Alex Gorsky, the Chairman and Chief Executive Officer will join the team for a Q&A session at 3:00 p.m. Pacific Time. Both sessions will be available to investors and those interested through the Johnson & Johnson website www.investor.jnj.com. A recording of the webcasts and podcast will be available two hours following each event. To learn more about Johnson & Johnson (JNJ) and to continue to track its progress visit the Vista Partners Johnson & Johnson Coverage Page.
Vista Partners LLC (”Vista”) is a California Registered Investment Advisor based in San Francisco. Vista delivers timely and relevant insights via the website: www.vistapglobal.com with daily stories, weekly market updates, monthly macroeconomic newsletters, podcasts, & Vista’s proprietary equity and market research to help you stay informed and stay competitive. Vista’s mission is to invest partner capital while arming investors with a comprehensive global financial perspective across all market sectors. Vista also seeks to provide select issuers with actionable advice regarding fundamental development, corporate governance, and capital market directives.
Stay Informed! Stay Competitive!